204 related articles for article (PubMed ID: 11837505)
1. The use of bisphosphonates in children with osteogenesis imperfecta.
Glorieux FH
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1491-5. PubMed ID: 11837505
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of osteogenesis imperfecta with bisphosphonates].
Tau C
Medicina (B Aires); 2007; 67(4):389-95. PubMed ID: 17891938
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?
Rauch F; Glorieux FH
Ann Med; 2005; 37(4):295-302. PubMed ID: 16019729
[TBL] [Abstract][Full Text] [Related]
4. Osteogenesis imperfecta, current and future medical treatment.
Rauch F; Glorieux FH
Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):31-7. PubMed ID: 16278881
[TBL] [Abstract][Full Text] [Related]
5. Experience with bisphosphonates in osteogenesis imperfecta.
Glorieux FH
Pediatrics; 2007 Mar; 119 Suppl 2():S163-5. PubMed ID: 17332237
[TBL] [Abstract][Full Text] [Related]
6. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
DiMeglio LA; Ford L; McClintock C; Peacock M
Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate therapy for severe osteogenesis imperfecta.
Glorieux FH
J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():989-92. PubMed ID: 11086652
[TBL] [Abstract][Full Text] [Related]
8. Osteogenesis imperfecta.
Huber MA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):314-20. PubMed ID: 17223585
[TBL] [Abstract][Full Text] [Related]
9. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
Land C; Rauch F; Travers R; Glorieux FH
Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
[TBL] [Abstract][Full Text] [Related]
10. Osteogenesis imperfecta.
Bhadada SK; Santosh R; Bhansali A; Upreti V; Dutta P
J Assoc Physicians India; 2009 Jan; 57():33-6. PubMed ID: 19753756
[TBL] [Abstract][Full Text] [Related]
11. Osteogenesis imperfecta: questions and answers.
Shapiro JR; Sponsellor PD
Curr Opin Pediatr; 2009 Dec; 21(6):709-16. PubMed ID: 19907330
[TBL] [Abstract][Full Text] [Related]
12. Reduction of plasma taurine level in children affected by osteogenesis imperfecta during bisphosphonate therapy.
D'Eufemia P; Finocchiaro R; Zambrano A; Tetti M; Ferrucci V; Celli M
Biomed Pharmacother; 2007 May; 61(4):235-40. PubMed ID: 17275249
[TBL] [Abstract][Full Text] [Related]
13. Alendronate treatment in children with osteogenesis imperfecta.
Akcay T; Turan S; Guran T; Bereket A
Indian Pediatr; 2008 Feb; 45(2):105-9. PubMed ID: 18310788
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials.
Hald JD; Evangelou E; Langdahl BL; Ralston SH
J Bone Miner Res; 2015 May; 30(5):929-33. PubMed ID: 25407702
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta.
Löwing K; Aström E; Oscarsson KA; Söderhäll S; Eliasson AC
Acta Paediatr; 2007 Aug; 96(8):1180-3. PubMed ID: 17578486
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta.
Biggin A; Munns CF
Curr Osteoporos Rep; 2017 Oct; 15(5):412-418. PubMed ID: 28823022
[TBL] [Abstract][Full Text] [Related]
17. [Genetic basis for skeletal disease. Osteogenesis imperfecta].
Tanaka H
Clin Calcium; 2010 Aug; 20(8):1245-52. PubMed ID: 20675936
[TBL] [Abstract][Full Text] [Related]
18. Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta.
Kamoun-Goldrat A; Ginisty D; Le Merrer M
Eur J Oral Sci; 2008 Jun; 116(3):195-8. PubMed ID: 18471236
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series.
Schwartz S; Joseph C; Iera D; Vu DD
J Can Dent Assoc; 2008; 74(6):537-42. PubMed ID: 18644240
[TBL] [Abstract][Full Text] [Related]
20. No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates.
Malmgren B; Aström E; Söderhäll S
J Oral Pathol Med; 2008 Apr; 37(4):196-200. PubMed ID: 18321345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
